Sun Pharma to Distribute AstraZeneca's Branded Heart Drug in India

Source: Economic Times

Jun 10, 2015

Last week, Sun Pharmaceutical and AstraZeneca Pharma India entered into a distribution services agreement for AstraZeneca’s newly branded Axcer -- an updated version of AstraZenca's clot-fighting treatment, Brilinta.

AstraZeneca has been selling Brilinta in India since 2012. Under the terms of the collaboration, Sun Pharma will be promoting and distributing Axcer in India. According to Sun, this will enable AstraZeneca to expand usage of the molecule, while strengtheing Sun Pharma’s cardiology portfolio.

Both Brilinta and Axcer (Ticagrelor) work by preventing the formation of new blood clots and maintaining blood flow, helping reduce a patient’s risk of another heart attack.

Read the Economic Times press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments